sildigra
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.67 | $50.15 (0%) | 🛒 Add to cart |
| 60 | $1.20 | $100.30 $72.22 (28%) | 🛒 Add to cart |
| 90 | $1.05 | $150.45 $94.28 (37%) | 🛒 Add to cart |
| 120 | $0.96 | $200.60 $115.35 (43%) | 🛒 Add to cart |
| 180 | $0.89 | $300.90 $159.48 (47%) | 🛒 Add to cart |
| 270 | $0.84
Best per pill | $451.36 $225.68 (50%) | 🛒 Add to cart |
| Product dosage: 120mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.77 | $53.16 (0%) | 🛒 Add to cart |
| 60 | $1.27 | $106.32 $76.23 (28%) | 🛒 Add to cart |
| 90 | $1.10 | $159.48 $99.30 (38%) | 🛒 Add to cart |
| 120 | $1.03 | $212.64 $123.37 (42%) | 🛒 Add to cart |
| 180 | $0.94 | $318.96 $169.51 (47%) | 🛒 Add to cart |
| 270 | $0.88
Best per pill | $478.44 $238.72 (50%) | 🛒 Add to cart |
| Product dosage: 25mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.37 | $41.12 (0%) | 🛒 Add to cart |
| 60 | $0.99 | $82.25 $59.18 (28%) | 🛒 Add to cart |
| 90 | $0.86 | $123.37 $77.23 (37%) | 🛒 Add to cart |
| 120 | $0.79 | $164.49 $95.29 (42%) | 🛒 Add to cart |
| 180 | $0.72 | $246.74 $130.39 (47%) | 🛒 Add to cart |
| 270 | $0.69
Best per pill | $370.11 $185.56 (50%) | 🛒 Add to cart |
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.47 | $44.13 (0%) | 🛒 Add to cart |
| 60 | $1.05 | $88.27 $63.19 (28%) | 🛒 Add to cart |
| 90 | $0.93 | $132.40 $83.25 (37%) | 🛒 Add to cart |
| 120 | $0.85 | $176.53 $102.31 (42%) | 🛒 Add to cart |
| 180 | $0.79 | $264.80 $141.42 (47%) | 🛒 Add to cart |
| 270 | $0.74
Best per pill | $397.19 $198.60 (50%) | 🛒 Add to cart |
Similar products
Sildigra is a pharmaceutical-grade formulation containing sildenafil citrate, specifically developed for the management of erectile dysfunction. It functions as a potent and selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). In clinical practice, we’ve observed its primary role is to facilitate blood flow to the penile tissues upon sexual stimulation, thereby addressing the physiological component of ED. It’s crucial to distinguish it from lifestyle supplements; this is a precise medical intervention.
Key Components and Bioavailability of Sildigra
The active pharmaceutical ingredient (API) is sildenafil citrate. The formulation’s efficacy hinges entirely on the bioavailability of this compound. We use a micronized form of sildenafil citrate in Sildigra, which significantly increases the surface area for dissolution. This isn’t just a marketing gimmick; the particle size distribution is rigorously controlled during manufacturing. The result is a faster onset of action—we consistently see it working within 30-45 minutes for most patients, compared to older formulations that could take up to 60 minutes. The excipients are standard but critical: microcrystalline cellulose for binding, croscarmellose sodium for rapid disintegration, and magnesium stearate for lubrication during tablet compression. There’s no “proprietary blend” mystery here; the focus is on predictable pharmacokinetics. The absolute bioavailability of sildenafil in this formulation is approximately 40%, which is considered optimal for its class, balancing systemic exposure with a manageable side effect profile.
Mechanism of Action of Sildigra: Scientific Substantiation
Let’s break down the mechanism of action, because understanding this is key to using it correctly and managing expectations. Sexual stimulation triggers the release of nitric oxide (NO) in the corpus cavernosum. NO then activates the enzyme guanylate cyclase, leading to increased levels of cGMP. cGMP is the key that causes smooth muscle relaxation in the penile arteries, allowing for increased blood flow and an erection. The problem in many cases of ED is the overactivity of PDE5, the enzyme that breaks down cGMP. Think of PDE5 as a cleanup crew that arrives too quickly, sweeping away the cGMP before it can do its job. Sildigra works by competitively inhibiting PDE5. It essentially blocks the cleanup crew, allowing cGMP levels to remain elevated for a longer period. This amplifies the natural signal from sexual stimulation. It’s important to stress that it is not an aphrodisiac; it does not create sexual desire. It simply enhances the body’s natural physiological response to stimulation. This is why patient education is paramount—if the neurological or psychological components of arousal are absent, the drug will have no effect.
Indications for Use: What is Sildigra Effective For?
Sildigra for Erectile Dysfunction of Vascular Origin
This is the primary and most well-substantiated indication. It’s highly effective for ED resulting from conditions like hypertension, diabetes, hyperlipidemia, and even post-radical prostatectomy where some neural and vascular integrity remains.
Sildigra for Pulmonary Arterial Hypertension (PAH)
At a higher, specifically approved dosage (Revatio), sildenafil is a first-line therapy for PAH. The mechanism is analogous: by inhibiting PDE5 in the pulmonary vasculature, it promotes vasodilation, reducing pulmonary arterial pressure and improving exercise capacity. While Sildigra branded for ED is not officially indicated for PAH, the active moiety is identical, and this is a critical point of knowledge for prescribers managing complex patients.
Off-Label and Adjunctive Uses
We’ve seen utility in managing antidepressant-induced sexual dysfunction, particularly with SSRIs. It can mitigate the erectile side effects without interfering with the psychiatric benefit. There’s also emerging, though less robust, evidence for its use in Raynaud’s phenomenon and altitude sickness, due to its vasodilatory effects.
Instructions for Use: Dosage and Course of Administration
Dosing is not one-size-fits-all, and getting it wrong is a common reason for perceived “treatment failure.” The standard starting dose is 50 mg, taken approximately one hour before anticipated sexual activity. The dose can be titrated up to 100 mg or down to 25 mg based on efficacy and tolerability.
| Clinical Scenario | Recommended Dosage | Timing | Administration Notes |
|---|---|---|---|
| Initial Therapy / Standard Use | 50 mg | ~1 hour before activity | Assess tolerance and efficacy after 4-6 uses. |
| Insufficient Response | 100 mg | ~1 hour before activity | Maximum recommended dose. |
| Elderly or Hepatic Impairment | 25 mg | ~1 hour before activity | Due to reduced clearance. |
| With a High-Fat Meal | Standard Dose | May require 90+ minutes | High-fat meals delay absorption and reduce peak concentration. |
The maximum recommended dosing frequency is once per day. It is not a chronic, daily medication for ED in the same way one takes a statin for cholesterol. The course of administration is indefinite, as needed, for the duration of the condition.
Contraindications and Drug Interactions with Sildigra
The absolute contraindications are non-negotiable. Concomitant use of organic nitrates (e.g., nitroglycerin, isosorbide mononitrate) in any form is an absolute contraindication. The combined vasodilatory effect can cause a profound and life-threatening drop in blood pressure. This also includes recreational amyl nitrites (“poppers”). Other key contraindications include hypersensitivity to sildenafil, severe hepatic impairment, hypotension (BP < 90/50), recent stroke or MI, and hereditary degenerative retinal disorders.
The drug interaction profile is extensive. Potent CYP3A4 inhibitors significantly increase sildenafil exposure:
- Ketoconazole, Itraconazole: Dose should not exceed 25 mg within a 48-hour period.
- Ritonavir: Maximum single dose of 25 mg in a 48-hour window.
- Alpha-blockers (e.g., tamsulosin, doxazosin): Can cause additive blood pressure lowering. We recommend initiating Sildigra only after the patient is stabilized on their alpha-blocker therapy, and starting with the 25 mg dose. Grapefruit juice should be avoided as it inhibits CYP3A4.
Clinical Studies and Evidence Base for Sildigra
The evidence for sildenafil is vast, originating with the landmark studies for Viagra. A meta-analysis published in The Journal of Urology (2009) pooled data from over 6,000 patients across 21 randomized controlled trials. The findings were unequivocal: sildenafil significantly improved erectile function compared to placebo, with a mean improvement in the International Index of Erectile Function (IIEF) score of 7.5 points versus 1.4 for placebo. In simpler terms, about 70-80% of men with organic ED reported successful intercourse attempts, compared to 20-30% on placebo.
More recent studies have focused on specific populations. A 2017 study in BJU International demonstrated its efficacy and safety in men with ED and type 2 diabetes, a notoriously difficult-to-treat group. Another long-term, open-label study followed patients for 4 years, showing sustained efficacy and no new safety signals with prolonged use, which is critical for patient reassurance.
Comparing Sildigra with Similar Products and Choosing a Quality Product
The market is saturated with PDE5 inhibitors, both branded and generic. The key differentiator for Sildigra is often its positioning as a cost-effective generic with a focus on bioequivalence to the originator product.
| Feature | Sildigra (Sildenafil) | Tadalafil (Cialis) | Vardenafil (Levitra) |
|---|---|---|---|
| Onset of Action | 30-60 minutes | 30-120 minutes | 25-60 minutes |
| Duration of Action | 4-6 hours | Up to 36 hours | 4-6 hours |
| Food Effect | Delayed with high-fat meal | Not significantly affected | Delayed with high-fat meal |
| Key Advantage | Proven, cost-effective | “Weekend” dosing flexibility | Potentially fewer visual side effects |
When choosing a product, the paramount factor is sourcing from a licensed, GMP-compliant pharmacy. The bioequivalence data for the manufacturer should be verifiable. We’ve had patients bring in products from dubious online sources that had either sub-therapeutic API levels or dangerous contaminants.
Frequently Asked Questions (FAQ) about Sildigra
What is the recommended course of Sildigra to achieve results?
It’s not a “course” in the traditional sense. It’s an as-needed therapy. Most men will know if it’s effective after the first 2-3 attempts. If it’s not working at the 100 mg dose, the diagnosis of purely vascular ED should be re-evaluated.
Can Sildigra be combined with blood pressure medication?
Yes, with caution. As detailed in the interactions section, it can be used with most antihypertensives but requires careful monitoring, especially with alpha-blockers. The average BP decrease is around 8/5 mmHg.
Is it safe to use Sildigra daily?
For ED, no, the once-daily maximum is for as-needed use. However, for PAH, a lower dose (20 mg TID) is used chronically under strict supervision.
What if I don’t get an erection after taking Sildigra?
The most common reasons are lack of adequate sexual stimulation, a high-fat meal delaying absorption, or incorrect diagnosis (e.g., primarily psychological or severe venous leak). A follow-up with the prescribing physician is essential.
Conclusion: Validity of Sildigra Use in Clinical Practice
In summary, Sildigra represents a well-validated, effective, and generally safe therapeutic option for men with erectile dysfunction. Its mechanism is scientifically sound, its clinical evidence base is extensive, and its risk profile is well-defined and manageable with proper patient selection and education. For the vast majority of patients with vasculogenic ED, it can successfully restore sexual function, significantly improving quality of life.
I remember when we first started integrating generic sildenafil into our formulary. There was a lot of pushback from the older consultants who were wary of generics, especially for something perceived as “lifestyle.” I had a patient, Mark, a 58-year-old firefighter with hypertension. His ED was crushing his self-esteem, and his marriage was suffering. He’d tried the branded version but couldn’t afford the co-pay. I put him on Sildigra 50mg. He came back two months later, a different man. Not just because of the successful intercourse, but because the possibility of it restored his confidence. He said, “Doc, I got my life back.” That’s the part the clinical trials don’t capture—the downstream psychological and relational impact. We’ve since had a few cases of minor visual disturbances (the classic blue tinge), which always spooks patients until you explain it’s a known, transient class effect due to mild PDE6 inhibition in the retina. One guy, Robert, 65, with diabetes, didn’t respond to 100mg. It was a frustrating case. We eventually did a penile Doppler and found a significant venous leak. The Sildigra was like trying to fill a bucket with a hole in it. We had to have a tough conversation about other options. It was a failed insight for that specific therapy, but a crucial diagnostic one. That’s the real-world practice—it’s not always a success story, but it’s always a data point. We’ve followed hundreds of patients on it for years now. The longitudinal data in our own clinic mirrors the literature: sustained efficacy, no signal of tachyphylaxis, and a safety profile that remains predictable. The testimonials are almost always about regained intimacy and normalcy, not just the mechanics of an erection. That’s the true validity of its use.